DOJ strategy to combat prescription opioid, heroin crisis: 5 things to know

As part of the federal governments ongoing efforts to curb prescription opioid and heroin addiction in the U.S., the Department of Justice issued a three-part strategy to address the public health challenges resulting from the epidemic.

Advertisement

The strategy focuses on three components: prevention, enforcement and treatment.

Here are five things to know about the DOJ’s strategy to combat the prescription opioid and heroin epidemic.

1. Attorney General Loretta Lynch sent a letter to state governors calling on them to strengthen the effectiveness of prescription drug monitoring programs.

2. The department will offer an $8.8 million grant to 20 states to help them reduce prescription abuse, misuse and diversion.

3. The department will promote the use of its naloxene among state, local and tribal law enforcement agencies that do not already adhere to a naloxone program. Naloxone is a medication used to counter the effects of opioid overdose.

4. The federal Drug Enforcement Agency will direct its resources toward combating those factors contributing to the epidemic, including individuals and institutions responsible for the trafficking of heroin and fentanyl.

5. The Bureau of Prison will commit to implementing a nationwide plan to expand medication-assisted treatment to all residential reentry centers, subject to funding.

More articles on legal and regulatory issues:
Kansas hospital unaware of federal probe into CFO
Judge terminates whistleblower’s lawsuit against Chapters Health System
Judge to decide if Colusa hospital can reopen under new management

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.